|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | ||
| Stock-based compensation | ||
| Foreign exchange (gain) loss, net | ||
| Performance bonds Facility Fee | ||
| Loss on remeasurement of assets classified as held for sale | ||
| Accretion of asset retirement obligations | ||
| Checkerboard fee | ||
| Accrued interest income | ||
| Interest expense | ||
| Non-cash interest on convertible notes | ||
| Loss on extinguishment of debt | ||
| Fair value loss on convertible debt | ||
| Changes in operating assets and liabilities: | ||
| Trade and other receivables | ||
| Prepaid expenses and other assets | ||
| Accounts payable and accrued expenses | ||
| Other non-current liabilities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Payments for property, plant and equipment | ||
| Payments for exploration and evaluation | ||
| Payments for assets under construction | ||
| Payment of interest on finance lease liabilities | ||
| Proceeds from research and development tax credit | ||
| Payment of interest on borrowings | ||
| Payment for Falcon Acquisition, including transaction costs, net of cash acquired | ||
| Payments in relation to assignment of notes receivable | ||
| Proceeds from sale of assets held for sale | ||
| Proceeds from government grants for exploration | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Contributions received from noncontrolling interest holders | ||
| Advance contributions received from noncontrolling interest holders | ||
| Common stock issue transaction costs | ||
| Proceeds from borrowings | ||
| Payment of debt issuance costs | ||
| Payment of transaction costs on common stock, awaiting issuance | ||
| Advance payment of common stock issue transaction costs | ||
| Payment of performance bond facility establishment fee | ||
| Repayment of lease liabilities | ||
| Net cash from financing activities | ||
| Net increase (decrease) in cash and cash equivalents and restricted cash | ||
| Cash and cash equivalents and restricted cash at the beginning of period | ||
| Effects of exchange rate changes on cash and cash equivalents | ||
| Cash and cash equivalents and restricted cash at the end of period | ||
| Supplemental cash flow information: | ||
| Non-cash investing and financing activities: | ||
| Accrued capital expenditure | ||
| Accrued stock issuance costs | ||
| Asset retirement obligations | ||
| Stock-based compensation | ||
| Stock-based compensation reserve | ||
| Contribution receivable from noncontrolling interest holders | ||
| Operating lease right-of use assets and lease liabilities | ||
| Interest accrued on finance lease liabilities | ||
| Finance lease right-of-use assets and lease liabilities | ||
| Accrued debt issuance costs | ||
| Interest and fee payable | ||
| Non-cash finance lease costs capitalized to unproved properties | ||
| Extinguishment of accrued capital expenditure | ||
| Convertible notes issued in exchange of extinguishment of debt | ||
| Common stock for conversion of convertible notes | ||
| Non-cash equity considerations | ||
| Accrued transaction costs | ||
| Equity consideration for Falcon Acquisition |
Loading...
